PSMA-Directed Theranostics in Prostate Cancer
Following lung cancer, prostate cancer is the leading cause of cancer death in men. High-risk localized tumor burden or metastatic disease often progresses, refractory to initial treatment regimens. There is ongoing development of technology to appropriately identify high-risk patients, stage them c...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/8/1837 |